Economic information and modeling reportBudget impact model
Cost assumptions
1 evidence topic · 1 source
Repeat dosing and average drug costs
| Input | Quoted value |
|---|---|
| Patients receiving a second dose | “6.5%” |
| Mean drug cost before rebate, excluding VAT | “€331,183” |
| Mean drug cost after rebate, excluding VAT | “€303,032” |